Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Join the brightest minds in regulatory at the annual Regulatory Convergence. See the global regulatory community in action. Intensive workshops. Topical sessions. Meet ups with regulators. This is where it all comes together.
For 20 years, our flagship publication, Fundamentals of US Regulatory Affairs, has been giving regulatory professionals the insights and answers they need, right at their fingertips.
There are hundreds of RAC testing centers available worldwide. Any of the four RAC exams (US, EU, CAN or Global) may be taken at any location. Find an upcoming exam at a location near you.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
Posted 02 April 2014 | By Louise Zornoza,
On 31 March 2014, the China Food and Drug Administration (CFDA) and China's State Council Legislative Affairs Office announced the first major overhaul of the regulations governing medical devices since the system's inception in April 2000.
The end product of six years of effort, the amended Regulations on the Supervision and Administration of Medical Devices are scheduled to go into effect on 1 June 2014, with additional implementing rules to be released over the next few months.
The new regulations establish three classes of device based on the degree of risk posed, from low to high. Products in the low risk class (Class 1) will only need to file documentation with the relevant municipal FDA, whereas moderate (Class 2) and high (Class 3) risk devices will be subject to premarket review and approval by CFDA.
The new regulatory scheme tightens regulatory control of the industry, with more stringent good manufacturing practice (GMP) and good supply practice (GSP) compliance and strengthened post-market supervision requirements. Fines for illegal manufacturing or selling of medical equipment will be up to 20 times the value of the goods, as compared to the cap of 5 times the value in the original rule. In the most serious cases, companies can be barred from applying or renewing the relevant licenses or permits for five years.
The regulations do, however, also include provisions to encourage innovation. For instance, authorizations will only be required for clinical trials on certain high-risk Class 3 devices, and will not be required at all for Class 2 devices; devices in both those classes with documented safety records can be exempt from clinical studies altogether.
Read all Breaking News from RegLink
Tags: Medical Device Regulation, Class, GMP, medical device
Regulatory Focus newsletters
All the biggest regulatory news and happenings.